We are live on ! Find out more
FTXH icon

First Trust Nasdaq Pharmaceuticals ETF
FTXH

26 hedge funds and large institutions have $11.9M invested in First Trust Nasdaq Pharmaceuticals ETF in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

69% more capital invested

Capital invested by funds: $7.04M → $11.9M (+$4.87M)

37% more funds holding

Funds holding: 19 → 26 (+7)

10.73% more ownership

Funds ownership: 44.87% → 55.6% (+11%)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

Holders
26
Holders Change
+7
Holders Change %
+36.84%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
LPL Financial
LPL Financial
California
+$1.31M
2
MIM
Marshall Investment Management
Colorado
+$1.3M
3
OMC
Old Mission Capital
Illinois
+$499K
4
PAG
Private Advisor Group
New Jersey
+$354K
5
OIA
OneDigital Investment Advisors
Kansas
+$304K

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$588K
2
WFA
WMG Financial Advisors
Tennessee
-$306K
3
UBS Group
UBS Group
Switzerland
-$145K
4
SC
Steph & Co
Wisconsin
-$142K
5
SWP
Stratos Wealth Partners
Ohio
-$13.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$30 – – –
WFA
27
WMG Financial Advisors
Tennessee
– -$306K -10,726 Closed
SC
28
Steph & Co
Wisconsin
– -$142K -4,990 Closed
1
2